Systemic sclerosis (SSc) is a complex human disorder characterized by progressive skin fibrosis. To better understand the molecular basis of dermal fibrosis in SSc, we analyzed microarray gene expression in skin of the Tight-skin (Tsk) mouse, an animal model where skin fibrosis is caused by an in-frame duplication in fibrillin-1 (Fbn-1). Tsk skin showed increased mRNA levels of several genes involved in Wnt signaling, including Wnt2, Wnt9a, Wnt10b and Wnt11; Dapper homolog antagonist of b-catenin (DACT1) and DACT2; Wnt-induced secreted protein 2; and secreted frizzled-related protein (SFRP)2 and SFRP4. RNase protection and northern blot confirmed microarray results. Furthermore, Wnt3a markedly stimulated matrix assembly of microfibrillar proteins, including Fbn-1, by cultured fibroblasts, suggesting that Wnts contribute to increased microfibrillar matrices in Tsk skin. Further analysis showed that SFRP4 expression is specifically increased in tissues expressing Tsk-Fbn-1, such as skeletal muscle and skin. The increase in SFRP4 mRNA in Tsk skin started 2 weeks after birth, following the increase in Wnt2 mRNA that occurred at birth. This suggests that SFRP4 may modulate Wnt functions in Tsk skin fibrosis. Lesional skin from SSc patients also showed large increases in SFRP4 mRNA and protein levels in the deep dermis compared to healthy skin, suggesting that the Wnt pathway might regulate skin fibrosis in SSc.
INTRODUCTION
Systemic sclerosis (SSc) or scleroderma is a chronic heterogeneous connective tissue disease featuring cutaneous and visceral fibrosis, autoimmunity, and vascular injury (Varga and Abraham, 2007) . Skin fibrosis results from excessive deposition of extracellular matrix proteins, especially type I collagen, but its pathogenesis remains unclear (Fleischmajer et al., 1983; Kissin and Korn, 2003; Denton et al., 2006) . Animal models for SSc such as the Tight-skin (Tsk) mouse (Green et al., 1976; Kasturi et al., 1994) , as well as genetic studies, have shown an association between fibrosis and fibrillin (Fbn-1) mutations. The phenotype of the Tsk mouse is caused by a large in-frame duplication of exons 17-40 of Fbn-1 and models certain dermal features of SSc (Siracusa et al., 1996; Saito et al., 1999; Pablos et al., 2004) . Fbn-1 is the major structural protein of connective tissue microfibrils, which are key components of elastic fibers. In addition to phenotypic similarities to SSc, such as increased skin thickness and tethering, Tsk mice also show certain pathologic similarities to SSc in upregulated expression of microfibrillar proteins Fbn-1, fibulin-2, and microfibrilassociated glycoprotein-2 (MAGP-2) (Fleischmajer et al., 1983; Lemaire et al., 2004a Lemaire et al., , b, 2005 Lemaire et al., , 2007 . These similarities suggest that a more complete understanding of the pathophysiology of Tsk mouse may provide an insight into matrix biology relevant to SSc. In addition, the Tsk model offers a special opportunity to examine how a well-defined alteration in a matrix protein, Fbn-1, is communicated to cells in the matrix and leads to skin fibrosis and associated widespread changes in matrix composition (Lemaire et al., 2006) .
Over the last years, several groups have used microarray analyses to obtain RNA expression profiles of skin from SSc patients (Zhou et al., 2001; Whitfield et al., 2003; Gardner et al., 2006) . Among regulated genes, downregulation of Wnt inhibitory factor, as well as upregulation of secreted frizzledrelated protein 4 (SFRP4) was detected in SSc. However, Wnt-related signaling has not been investigated previously in SSc or Tsk mice. Although the potential role of Wnt signaling in dermal matrix regulation is unclear, distinctive Wnt members have been shown to regulate the hierarchical morphogenesis of skin regions in embryonic chicken . The early changes of skin tethering in Tsk mice, which can be appreciated shortly after birth, suggest that matrix dysregulation in Tsk might represent developmental dysregulation. Although the role of Wnts in skin fibrosis is unknown, SFRP4, a member of the SFRPs shown to inhibit Wnt signaling, has previously been implicated in kidney fibrosis (Surendran et al., 2005) .
Multiple proteins are involved in the complex regulation of Wnt-mediated developmental processes (Clevers, 2006; Gordon and Nusse, 2006; Kikuchi et al., 2006) . The transduction of Wnt signals toward transcription activation of targets genes is initiated by binding of extracellular Wnt ligands to Frizzled seven-pass transmembrane receptors. After receptor activation, intracellular signals are transduced through the canonical Wnt/b-catenin and non-canonical pathways. Intracellular Dapper homolog antagonist of b-catenin (DACT) proteins have been shown to inhibit both Dishvelled (Dvl)-mediated canonical and non-canonical Wnt pathways. Other proteins that might be important in downstream signaling by Wnts include the Wnt-induced secreted proteins (WISP), named WISP-1/CCN4, WISP-2/CCN5, and WISP-3/CCN6, also members of the CCN family of growth factors.
SFRPs are a five-member family of extracellular proteins that were first identified as Wnt signaling repressors that interact with both Wnt ligands and their Frizzled receptors (Finch et al., 1997; Melkonyan et al., 1997; Uren et al., 2000) . SFRPs also bind to proteins structurally unrelated to Wnts (Hausler et al., 2004; Lee et al., 2004) . SFRPs are secreted Wnt inhibitors that contain an N-terminal region homologous to the extracellular cysteine-rich domain of the Frizzled family proteins but lack the transmembrane and intracellular regions required for anchoring to the plasma membrane and signaling transduction, respectively (Rattner et al., 1997; Jones and Jomary, 2002) .
In this study, we have identified by microarray analysis a comprehensive list of genes overexpressed in Tsk mouse skin. The most highly increased genes fall into four main groups: microfibrill-associated genes, collagen genes, Wnt-signaling pathway genes, and other developmental regulator genes, including bone morphogenetic proteins (BMPs) and CCNs. Here we show that several genes of the Wnt pathway are highly increased in Tsk skin, including Wnt2, Wnt9a, Wnt10b, Wnt11, DACT1, DACT2, WISP2, and SFRP4. Wnt is shown to increase Fbn matrix formation in vitro, a key pathogenic feature in Tsk hypodermis. Further, we show that SFRP4 is highly upregulated in skin from Tsk mice and from SSc patients. Together, these data suggest that Wnt stimulation plays an important role in matrix remodeling in Tsk mice and supports potential related roles in dermal fibrosis in SSc patients.
RESULTS

Wnt signaling is increased in Tsk mice skin
To better understand the molecular mechanisms of skin fibrosis in Tsk mice, we analyzed gene expression in the skin of 6-week-old wild-type (WT) and Tsk mice using Affymetrix Genechips arrays. Genes with the highest upregulation in Tsk skin were microfibrillar genes, collagen genes, Wnt signaling pathway genes, and other developmental regulators BMPs and CCNs (Table 1) . Increases in microfibrillar MAGP-2 (MFAP5), Fbn-1, and fibulin-2 confirmed our previously published data (Lemaire et al., 2004a (Lemaire et al., , b, 2005 . Several Wnt genes and genes involved in mediating or antagonizing Wnt signals were highly upregulated, including Wnt2, Wnt9a, Wnt11, DACT1/DACT2, WISP2, and SFRP2/SFRP4. RNase protection assay targeting Wnt mRNAs confirmed the microarray data ( Figure 1 ). Wnt2 was most highly upregulated (4.07-fold increase in Tsk compared to WT skin). Although Wnt9a was not detected, Wnt3a, Wnt10b, and Wnt11 were also modestly increased in Tsk skin (1.3-, 1.4-, and 1.9-folds, respectively).
SFRP4 expression is increased in Tsk mouse skin
In addition to upregulated Wnt expression, the Tsk microarray data showed highly upregulated SFRP2 and SFRP4 mRNAs in Tsk skin. To validate our microarray results, we analyzed SFRP4 RNA and protein in skin of matching pairs of 8-week-old Tsk and control mice using northern blot and western blot. SFRP4 mRNA was markedly increased in Tsk skin compared to WT mice skin (6.2-fold; Figure 2a ). This was confirmed by real-time PCR analysis (data not shown). Expression of SFRP4 was similarly increased at the protein level in skin of Tsk mice compared to control mice (4.0-fold; Figure 2b ). Upregulation of Wnt2, WISP2, DACT1, and SFRP2 genes was also confirmed by northern blot analysis ( Figure 3 and data not shown).
Wnt2, SFRP4, and Tsk Fbn-1 mRNA expressions are coregulated in tissues from Tsk mice To better understand the relationship between increased Wnt2, SFRP4, and Tsk-Fbn-1, we looked at the expression of these genes in various adult tissues by northern blot. Skin, skeletal muscle, and heart tissues, and to a lesser degree kidney tissue, from Tsk mice showed high upregulation of Fbn-1 and Tsk-Fbn-1 mRNAs compared to Fbn-1 mRNA in WT mice ( Figure 3a ). Notably, Wnt2 and SFRP4 expression mostly followed expression of Fbn-1 and Tsk-Fbn-1, as Wnt2 and SFRP4 mRNAs were highly upregulated in Tsk skeletal muscle and skin. Heart and kidney tissues showed lower levels of SFRP4 and detectable Fbn-1, whereas expressions of Fbn-1 and SFRP4 were undetectable in the brain, spleen, and liver (Figure 3a and b). These data suggested that Wnt2 and SFRP4 contribute to the effects of Tsk-Fbn on matrix remodeling.
The onset of increased SFRP4 mRNA in Tsk skin is post-natal and follows increased Wnt2 mRNA To better understand how Wnts might developmentally regulate the matrix abnormalities in Tsk skin, we analyzed Wnt2 and SFRP4 mRNA in skin of mice of different ages by northern blot. Tsk mice showed both WT and Tsk-Fbn-1 mRNA transcript expression from the earliest age analyzed (embryo stage E18.5) that continued at a lower level in weaned mice (4 weeks). WT mice showed only the WT Fbn-1 transcript in the same pattern (Figure 4a , first panel). Importantly, increased expression of SFRP4 mRNA was not detected until 2 weeks after birth in Tsk skin, increasing further over time (Figures 2a, 4a and b) . Unlike SFRP4, Wnt2 showed upregulation as soon as birth ( Figure 4c and d), suggesting that Wnt2 might function before SFRP4 in altering the phenotype of Tsk mice.
Wnt stimulates Fbn matrix assembly
We have previously described that Tsk mice show marked increases in hypodermal Fbn matrix (Lemaire et al., 2004b) .
To determine whether the Wnt pathway might mediate matrix remodeling in Tsk skin, we looked at its effect on Fbn matrix in vitro. Based on commercial availability and activation of the canonical b-catenin pathway, this investigation was carried out using Wnt3a. Treatment of mouse embryonic fibroblasts (MEF) by Wnt3a increased by more than threefold the level of Fbn-1 deposited within the extracellular matrix, while not affecting the non-microfibrillar protein fibronectin ( Figure 5a ). As Wnt3a treatment did not change the levels of Fbn-1 mRNA (Figure 5b , left panel) and Fbn-1 protein in the medium (Figure 5b , right panel), this result suggests that Wnt3a regulates matrix assembly of Fbn-1. Increased levels of Fbn-1 deposited in the matrix after treatment with Wnt3a were also seen in culture of primary skin fibroblasts isolated from normal and SSc patients ( Figure   5c ). Wnt3a also markedly stimulated matrix deposition of other microfibrillar proteins, including MAGP-2 and elastin ( Figure 5d ), similar to transforming growth factor-b (TGF-b) (Kissin et al., 2002; Lemaire et al., 2005 Lemaire et al., , 2007 . However, Wnt3a treatment of MEFs did not induce phosphorylation of Smad3, unlike TGF-b (Figure 5e ), suggesting that Wnt3a stimulates matrix assembly of Fbn-1 independently of activation of the canonical Smad-dependent TGF-b pathway.
SFRP4 mRNA expression is increased in the skin of SSc patients
A review of microarray data from Whitfield et al. (2003) , Gardner et al. (2006) , and our unpublished observations from skin of patients with SSc showed strikingly increased SFRP4 expression compared to control skin. To determine whether SFRP4 expression was altered in SSc, we analyzed SFRP4 mRNA in lesional and non-lesional skin from 12 SSc patients and four healthy control subjects by quantitative real-time PCR (Table 2) . SFRP4 mRNA was detected at a low level in healthy skin and was significantly increased in lesional skin of SSc patients ( Figure 6 , 7.2-fold increase). A more moderate but significant increase of SFRP4 mRNA was also detected in non-lesional skin of the same SSc patients compared to healthy subjects ( Figure 6 , 3.7-fold increase). To determine whether and where increased expression of SFRP4 protein was present in vivo, lesional skin from 19 patients with SSc and 12 healthy controls was analyzed with a rabbit polyclonal anti-SFRP4 antibody by immunohistochemistry. Consistent with reverse transcription-PCR data, SFRP4 protein was increased in SSc skin compared to healthy skin (Figure 7a protein level (Figure 7e ). SFRP4 staining was observed at similar levels around blood vessels and in the epidermal layer of both healthy and SSc skin.
DISCUSSION
The molecular mechanisms underlying skin fibrosis in SSc and in Tsk mice remain poorly understood. In this study, we describe the overexpression of several Wnt signaling molecules in the skin of Tsk mice and extend these observations to human SSc. We find that Wnt signaling is affected in Tsk skin at several levels. Several Wnt genes, including Wnt2a, Wnt9a, Wnt10b, and Wnt11, are highly upregulated, as well as mediators and regulators of Wnt signaling, including intracellular molecules such as DACT1/2 and WISP2, and extracellular molecules such as SFRP2 and SFRP4. Finally, Wnt signaling increased Fbn fibrillinogenesis in vitro, a key aspect of skin fibrosis in Tsk mice. Despite reports of decreased stability of Fbn matrix produced by SSc fibroblasts in vitro (Wallis et al., 2001) , Fbn matrix is increased in the dermis of SSc skin (Fleischmajer et al., 1991) . Thus, our results suggest that Wnt signaling might contribute to upregulated Fbn matrix in Tsk and SSc skin. How the Tsk-Fbn-1 mutation induces altered hypodermal matrix and skin tethering is unknown. Our study suggests that skin fibrosis and matrix remodeling may be mediated in Tsk mice by developmental regulators, in particular Wnts. Importantly, we show that Wnt expression is increased in skin and other Fbn-containing tissues in Tsk mice during late development, at times before the phenotype of these animals is readily detectable. These data strongly suggest that the Tsk-Fbn-1 mutation affects late developmental processes at around the time that Fbn-1 protein can first be detected (Quondamatteo et al., 2002) . The mechanism behind altered expression of the Wnt family is unclear. However, we show that treatment of fibroblasts by Wnt3a markedly stimulates deposition of Fbn-1. As Fbn-1 is dramatically increased in the hypodermal layer of Tsk mice, these results suggest that Wnt upregulation may play a direct role in the altered matrix in Tsk mice. The importance of Wnt signaling in skin remodeling in Tsk is consistent with the function of Wnts in skin morphogenesis in embryonic chicken . Indeed, involvement of Wnt signaling has been observed in various sites of epithelial-mesenchymal interaction (Maretto et al., 2003) and it is considered to be critical for the establishment of hair follicles during embryonic development (Reddy et al., 2001; Andl et al., 2002) . Our results suggest that the Wnts may also play an important function in regulating hypodermal development, such that alterations in Fbn, one of the most abundant proteins in the hypodermis, are in some manner transmitted to the developing mesenchymal cells to alter Wnt expression and matrix composition.
Our study shows a large increase in SFRP4 in the skin of Tsk mice. SFRP4, also known as DDC-4/rFrp rat homolog (Wolf et al., 1997) , human FrpHE (Abu-Jawdeh et al., 1999), or FrzB-2 Xenopus homolog, is a secreted glycoprotein previously reported as expressed in various tissues (Rattner et al., 1997; Leimeister et al., 1998; James et al., 2000; Schumann et al., 2000; Tebar et al., 2001; Yam et al., 2005) . We show that SFRP4 mRNA expression was detectable in only select normal tissues from adult mice, and that its expression markedly increased in Tsk skin and skeletal muscle. The pattern of expression is consistent with pathological examination of Tsk muscle, which shows a large increase in connective tissues surrounding the muscle (unpublished observation), suggesting that SFRP4 expression and other genes in Tsk mouse are selectively increased in Fbn-rich hypodermal connective tissue and facia between the skin and skeletal muscle.
Although the functions of SFRPs are incompletely understood, they are best characterized as repressors of (Surendran et al., 2005) . Together, these data suggest that increased SFRP4 in Tsk skin may represent a counterregulatory mechanism of Wnt activity. This is consistent with the late increase in SFRP4 levels in Tsk skin following an earlier increase in Wnt2 levels. We extended our observations in Tsk skin to human SSc and showed significantly Our results highlight the possibility that fibrosis in SSc may be regulated by several different cytokines . Previous studies have indicated important roles for cytokines in the development of fibrosis in SSc, in particular TGF-b (Chen et al., 2006) , and connective tissue growth factor (CTGF/CCN2) (Igarashi et al., 1995; Shi-wen et al., 2000; Leask et al., 2002) . Two groups have recently identified a large set of genes that are upregulated in SSc skin, some of which are known to be induced by TGF-b (Whitfield et al., 2003; Gardner et al., 2006) . These microarray studies also showed dysregulation of several molecules in the Wnt pathway, including downregulation of Wnt inhibitory factor as well as upregulation of SFRP4. Although the role of increased SFRP4 expression in SSc remains unclear, its effect might be to antagonize upregulated Wnt expression in affected tissues. As shown in the Tsk mouse, such regulation might have important effects on matrix composition.
In conclusion, this report provides new evidence for a potential role of Wnts and Wnt antagonists in regulating dermal matrix composition in SSc and Tsk mice. Further understanding of the role of Wnts and Wnt antagonists in Tsk mice should provide an insight into matrix regulation during development and pathologic fibrosis.
MATERIALS AND METHODS
Patients and controls
All patients with SSc had diffuse cutaneous disease, according to the American College of Rheumatology criteria for SSc. Controls had no history of skin disease. Punch biopsies were obtained from the dorsal mid-forearm, an area of skin that was affected in all of the patients with SSc. Biopsies were performed after patient written consent and with approval of the Institutional Review Board for Human Studies at Boston University Medical Center. The study was conducted according to the Declaration of Helsinki Principles.
Animals C57BL/6-Fbn-1 Tsk þ / þ Pldn pa mice (Tsk/ þ ) were obtained from the Jackson Laboratory (Bar Harbor, ME), and produced by breeding of Tsk/ þ with C57BL/6 mice according to an approved Institutional Animal Care and Use Committee protocol. Tsk mice were identified by manual assessment of skin tightness over the back and genotyping by PCR amplification on tail genomic DNA using the following Fbn-1 primers: 5 0 -CCAGACTACATGCAAGTGAACGG-3 0 and 5 0 -CCTTTCCTGGTAACATAGGAAAGC-3 0 .
Cell culture
MEFs, MEF-TE cells overexpressing tropoelastin-enhanced green fluorescent protein and conditionally overexpressing mouse MAGP-2 (Lemaire et al., 2005; Lemaire et al., 2007) , and human dermal fibroblasts from normal volunteers or patients with SSc obtained as previously described (Kissin et al., 2002) were grown in 10% fetal bovine serum-supplemented DMEM (Gibco, Carlsbad, CA) at 371C in a humidified 8% CO 2 incubator. Cells were cultured in the presence or absence of 100 ng/ml Wnt3a (R&D Systems, Minneapolis, MN). Figure 6 . Expression of SFRP4 mRNA is increased in the skin of SSc patients compared to healthy controls. Total RNA was extracted from the skin of four healthy control subjects (n ¼ 4) and from lesional (n ¼ 11) and non-lesional skin (n ¼ 8) areas of patients with SSc, as described in Table 2 . SFRP4 expression was analyzed by quantitative real-time PCR. SFRP4 values were normalized to 18S rRNA. Horizontal lines indicate mean7SEM. Statistical significance was assessed using t-test for independent samples. *P-values less than 0.05 were considered significant: control versus lesional skin P ¼ 0.018; control versus non-lesional skin P ¼ 0.021; lesional skin versus non-lesional skin P ¼ 0.040. Figure 7 . SFRP4 protein is increased in the dermis of SSc patients compared to healthy controls. Punch biopsies from SSc lesional skin (n ¼ 19) and control skin (n ¼ 12), as described in Table 2 , were embedded in paraffin and processed for immunohistochemistry analysis. Tissue sections of (a, c) normal healthy skin and (b, d) lesional skin were immunostained for SFRP4. Sections were counterstained with hematoxylin (blue). Arrows indicate positively stained cells (red). No staining was detected in the absence of primary antibody or with an isotype control antibody (data not shown (Brinkman, Westbury, NY) . After centrifugation for 10 minutes at 4,000 Â g, total RNA was purified, according to the manufacturer's protocol. Fresh human skin biopsies (1-3 mm) were put in RNA later (Qiagen, Carlsbad, CA) , and stored at À201C until processed. Tissues were transferred into RLT buffer (Qiagen), where they were thinly minced with scissors before being disrupted using a Polytron homogenizer. RNAs were purified from RLT buffer supernatant using the RNeasy total RNA kit, according to the manufacturer's protocol (Qiagen, Valencia, CA). RNA was extracted from fibroblasts using the RNeasy total RNA kit.
Healthy control skin
Gene profiling
To analyze gene expression in skin of Tsk and WT mice, cDNA synthesized from RNA purified from skin biopsies of the back of 6week-old littermate mice was hybridized to mouse microarray containing 39,000 mouse-gene transcripts (GeneChip s mouse genome 430.2.0, Affymetrix, Santa Clara, CA) and developed according to the Amplification for Eukaryotic Targets protocol (Affymetrix). The Boston University Microarray Facility performed these analyses as described previously (York et al., 2007) .
RNase protection assay
Validation of individual Wnt gene expression was performed using two custom multi-probe template sets to quantitatively determine expression of Wnt 1, 2, 3a, 3b, 4, 5b, and 6 (set mWnt-1 no. 550925; Pharmingen Corp., San Jose, CA), and 7a, 7b, 8d, 10a, 10b, 11, 13, and 15 (set mWnt-2 no. 550249; Pharmingen Corp.). Single-stranded 32 P-labeled cRNA probes were hybridized to purified RNA, digested, and analyzed by denaturing polyacrylamide gel electrophoresis, as described previously (Cho et al., 2002) . All gene expression was normalized to the L32 housekeeping gene expression.
Northern blot analysis
Total RNA (4 mg per lane) was separated by electrophoresis through a 1 M formaldehyde/1% agarose gel, blotted onto a nylon membrane (Hybond-N þ , Amersham Biosciences, Piscataway, NJ), UV crosslinked, and then hybridized overnight at 651C to random primed, [a-32 P] cDNA probe for SFRP4 (from clone no. 1364770, ATCC) or Wnt2 (gift from AP McMahon) or Fbn-1 (Kissin et al., 2002) . Prehybridization, hybridization, and washing of the filters were carried out according to the protocol of Church and Gilbert. The intensity of the signal was measured using a Phosphoimager (Cyclone; Perkin-Elmer, Wellesley, MA).
Reverse transcription and real-time quantitative PCR
cDNA was synthesized by reverse transcription of 0.5-1 mg of purified total RNA, using random primers (Applied Biosystems, Branchburg, NJ) and SuperScript II RNase H-Reverse Transcriptase (Invitrogen Life Technologies). Real-time PCR was performed on an ABI PRISM 7700 sequence Detector (Applied Biosystems) using human SFRP4 (Hs00180066) and human 18S ribosomal RNA (4319413E) TaqMan primers following the manufacturer's protocol (Applied Biosystems). PCR conditions were as follows: 501C for 2 minutes (UNG cleavage) and 951C for 10 minutes for one cycle, and then 951C for 15 seconds and 601C for 1 second for 40 cycles.
Each reaction was carried out in duplicate and normalized to the housekeeping internal control gene, 18S ribosomal RNA.
Western blot analysis
Skin samples were directly homogenized in Laemmli buffer containing 2% b-mercaptoethanol using a polytron homogenizer. Lysates were incubated at 41C for 30 minutes and centrifuged at 10,000 Â g for 20 minutes at 41C. MEFs were cultured in 0.1% serum containing DMEM for 16 hours in the presence or absence of Wnt3a. Media were collected and concentrated using centrifugal filters (Amicon ultra-4 10k, Millipore, Billerica, MA). Total lysates and secreted proteins were resolved on an SDS-PAGE gel, transferred to polyvinylidine difluoride membranes (Immobilon-P; Millipore) using standard methods, and then stained with Ponceau S. Membranes were then blocked in 5% milk or 5% BSA 0.05% Tween-trisbuffered saline for 1 hour, incubated overnight at 41C with monoclonal mouse anti-SFRP4 antibody (Berndt et al., 2003) , polyclonal rabbit anti-Fbn-1 (Ab9543, gift from L. Sakai), antibovine fibronectin (Calbiochem, San Diego, CA), anti-phospho Smad3 (Rockland, Gilbertsville, PA), or anti-Smad2/3 (Upstate, Billerica, MA) and then with a horseradish peroxidase-conjugated goat anti-mouse IgG antibody (Sigma, St. Louis, MO) or donkey antirabbit IgG (The Jackson Laboratory) for 1 hour. Signals were developed using Supersignal West Pico chemiluminescent reagent (Pierce, Rockford, IL) followed by autoradiography. Signal intensities were quantified using NIH image 1.63 software and normalized to total proteins.
Immunofluorescence
MEFs and human fibroblasts were grown in Lab-Tek eight-chamber culture slides (Nalge Nunc International, Naperville, IL), fixed for 10 minutes in 4% paraformaldehyde at room temperature, blocked for 30 minutes with 3% BSA-tris-buffered saline, and then incubated for 2 hours with polyclonal rabbit antiserum directed against mouse Fbn-1 (Ab9543, gift from L. Sakai), against MAGP-2 (gift from M. Shipley), or against fibronectin (Calbiochem) in 3% BSA/tris-buffered saline. Cells were then incubated for 1 hour with a rhodamineconjugated donkey anti-rabbit IgG (Jackson ImmnuoResearch, West Grove, PA). Nuclei were counterstained by treating cells for 5 minutes with 100 ng ml À1 Hoechst 33342 (Molecular Probes, Eugene, OR). Specific fluorescence signals were visualized by an Olympus BH-2 microscope under fluorescent light associated with high-resolution Olympus DP70 camera and quantified using NIH image 1.63 software.
Immunohistochemistry
Human skin biopsies from lesional areas of patients with SSc (n ¼ 19) and from healthy control subjects (n ¼ 12) were fixed with 4% paraformaldehyde, embedded in paraffin block, and mounted on glass slides. Skin sections were subsequently deparaffinized, dewaxed, and dehydrated through xylene and graded ethanol washes. Tissues were then blocked for 30 minutes with 3% BSAtris-buffered saline and incubated with rabbit polyclonal affinitypurified anti-SFRP4 antibody (1:70 dilution; kindly provided by Dr R. Friis) overnight at 41C. The slides were then rinsed in tris-buffered saline and incubated for 30 minutes at room temperature with alkaline phosphatase-conjugated polymer directed against mouse and rabbit Igs (Dako, Carpinteria, CA). Alkaline phosphatase www.jidonline.org 879 J Bayle et al.
activity was detected using Fast Red substrate (Envision, DakoCytomation). Tissues were counterstained with Mayer's hematoxylin (Sigma). Three different blinded observers graded SFRP4 staining in the papillary and deep reticular dermis using a scale from 0 (no staining) to 4 þ (maximal staining).
Statistical analysis
All data are presented as means7SD, and analyzed using unpaired Student's t-test or Mann-Whitney U-test. A P-value less than 0.05 was considered a significant difference.
